Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3

Autologous formalin-fixed tumor vaccine (AFTV) suppressed re-recurrence for more than 32 months of multiple-recurrent hepatocellular carcinoma based on hepatitis C virus-induced liver cirrhosis in a case with previous recurrence interval, 51-, 28-, 12-, and 4-months. We detected glypican-3-specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawashima, Issei, Kawashima, Yuri, Matsuoka, Yasuo, Fujise, Kiyotaka, Sakai, Hideki, Takahashi, Mari, Yoshikawa, Toshiaki, Nakatsura, Tetsuya, Ishihara, Takeshi, Ohno, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498860/
https://www.ncbi.nlm.nih.gov/pubmed/26185646
http://dx.doi.org/10.1002/ccr3.279
_version_ 1782380694725459968
author Kawashima, Issei
Kawashima, Yuri
Matsuoka, Yasuo
Fujise, Kiyotaka
Sakai, Hideki
Takahashi, Mari
Yoshikawa, Toshiaki
Nakatsura, Tetsuya
Ishihara, Takeshi
Ohno, Tadao
author_facet Kawashima, Issei
Kawashima, Yuri
Matsuoka, Yasuo
Fujise, Kiyotaka
Sakai, Hideki
Takahashi, Mari
Yoshikawa, Toshiaki
Nakatsura, Tetsuya
Ishihara, Takeshi
Ohno, Tadao
author_sort Kawashima, Issei
collection PubMed
description Autologous formalin-fixed tumor vaccine (AFTV) suppressed re-recurrence for more than 32 months of multiple-recurrent hepatocellular carcinoma based on hepatitis C virus-induced liver cirrhosis in a case with previous recurrence interval, 51-, 28-, 12-, and 4-months. We detected glypican-3-specific cytotoxic T lymphocytes in the peripheral blood at 12 months after AFTV.
format Online
Article
Text
id pubmed-4498860
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-44988602015-07-16 Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3 Kawashima, Issei Kawashima, Yuri Matsuoka, Yasuo Fujise, Kiyotaka Sakai, Hideki Takahashi, Mari Yoshikawa, Toshiaki Nakatsura, Tetsuya Ishihara, Takeshi Ohno, Tadao Clin Case Rep Case Reports Autologous formalin-fixed tumor vaccine (AFTV) suppressed re-recurrence for more than 32 months of multiple-recurrent hepatocellular carcinoma based on hepatitis C virus-induced liver cirrhosis in a case with previous recurrence interval, 51-, 28-, 12-, and 4-months. We detected glypican-3-specific cytotoxic T lymphocytes in the peripheral blood at 12 months after AFTV. John Wiley & Sons, Ltd 2015-06 2015-04-17 /pmc/articles/PMC4498860/ /pubmed/26185646 http://dx.doi.org/10.1002/ccr3.279 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Kawashima, Issei
Kawashima, Yuri
Matsuoka, Yasuo
Fujise, Kiyotaka
Sakai, Hideki
Takahashi, Mari
Yoshikawa, Toshiaki
Nakatsura, Tetsuya
Ishihara, Takeshi
Ohno, Tadao
Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title_full Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title_fullStr Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title_full_unstemmed Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title_short Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
title_sort suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498860/
https://www.ncbi.nlm.nih.gov/pubmed/26185646
http://dx.doi.org/10.1002/ccr3.279
work_keys_str_mv AT kawashimaissei suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT kawashimayuri suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT matsuokayasuo suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT fujisekiyotaka suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT sakaihideki suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT takahashimari suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT yoshikawatoshiaki suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT nakatsuratetsuya suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT ishiharatakeshi suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3
AT ohnotadao suppressionofpostsurgicalrecurrenceofhepatocellularcarcinomatreatedwithautologousformalinfixedtumorvaccinewithspecialreferencetoglypican3

Ejemplares similares